Humanigen Inc (fka HGENQ)

[cowtown jay]

I'm glad to see that you were aware of MLR's disease progression, and comeback. I just saw a picture of her at 55 years old, with a beautiful smile, when the news broke that she was given days to live, and felt compelled to ask management to help her, if they could.

But, I would not put it past our management to have recommended toci or gohibic to a patient that seriously ill, if they weren't confident lenz could be successful. If that happened, I would still credit management for their help.

However, if lenz really did help her survive pneumonia, I saw nothing saying that it was covid pneumonia. So I would like to see the case study. It wouldn't even need to include her name.

But you raise a deeper question that I have often wondered about. I think Mayo Clinic, as well as management, could have thousands of compassionate use outcomes, for many others like MLR. That data would also be capable of providing covid reinfection rates for those lenz-treated patients, which is probably the one thing I have long asked for without a reply from management.

But, yes, MLR could potentially be a real and lovable star in a Humanigen lenz promotion.